Noah Goodman's most recent trade in Kymera Therapeutics Inc was a trade of 18,450 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 18,450 | 18,450 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 9,225 | 59,306 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 50,000 | 50,081 | - | 0 | Common Stock |